Glomerular disease: Lupus nephritis treatment: Are we beyond cyclophosphamide?

Nature Reviews Nephrology

Volumn 5, Issue 9, 2009, Pages 492-494

  Rovin, Brad H ^a  

^a THE OHIO STATE UNIVERSITY COLLEGE OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AZATHIOPRINE; CORTICOSTEROID; CREATININE; CYCLOPHOSPHAMIDE; MYCOPHENOLIC ACID 2 MORPHOLINOETHYL ESTER;

CREATINE KINASE BLOOD LEVEL; CREATININE BLOOD LEVEL; DRUG DOSE TITRATION; DRUG SAFETY; HUMAN; KIDNEY BIOPSY; KIDNEY FUNCTION; LUPUS ERYTHEMATOSUS NEPHRITIS; PRIORITY JOURNAL; REMISSION; SHORT SURVEY; TREATMENT RESPONSE;

CYCLOPHOSPHAMIDE; HUMANS; IMMUNOSUPPRESSIVE AGENTS; KIDNEY GLOMERULUS; LUPUS NEPHRITIS;

EID: 70349335696     PISSN: 17595061     EISSN: 1759507X     Source Type: Journal    
DOI: 10.1038/nrneph.2009.130     Document Type: Short Survey

References (10)

1. Appel, G. B. et al. Mycophenolate mofetil versus cyclophosphamide for induction treatment of lupus nephritis. J. Am. Soc. Nephrol. 20, 1103-1112 (2009).
2. Ong, L. M. et al. Randomized controlled trial of pulse intravenous cyclophosphamide versus mycophenolate mofetil in the induction therapy of proliferative lupus nephritis. Nephrology (Carlton) 10, 504-510 (2005).
3. Hu, W. et al. Mycophenolate mofetil vs cyclophosphamide therapy for patients with Diffuse proliferative lupus nephritis. Chin. Med. J. (Engl.) 115, 705-709 (2002).
4. Chan, T. M. et al. efficacy of mycophenolate mofetil in patients with diffuse proliferative lupus nephritis. N. Engl. J. Med. 343, 1156-1162 (2000).
5. Ginzler, E. M. et al. Mycophenolate mofetil or intravenous cyclophosphamide for lupus nephritis. N. Engl. J. Med. 353, 2219-2228 (2005).
6. Chan, T. M., Tse, K. C., Tang, C. S. O., Mok, M.-Y. & Li, F. K. Long-term study of mycophenolate mofetil as continuous induction and maintenance treatment for diffuse proliferative lupus nephritis. J. Am. Soc. Nephrol. 16, 1076-1084 (2005).
7. Moroni, G. et al. The long-term outcome of 93 patients with proliferative lupus nephritis. Nephrol. Dial. Transplant. 22, 2531-2539 (2007).
8. Hill, G. S. et al. Predictive power of the second renal biopsy in lupus nephritis: significance of macrophages. Kidney Int. 59, 304-316 (2001).
9. Korbet, S. M., schwartz, M. M., evans, J. & Lewis, E. J. severe lupus nephritis: Racial differences in presentation and outcome. J. Am. Soc. Nephrol. 18, 244-254 (2007).
10. Mok, C. C. et al. Treatment of diffuse proliferative lupus glomerulonephritis: A comparison of two cyclophosphamide-containing regimens. Am. J. Kidney Dis. 38, 256-264 (2001).